Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
รหัสบริษัทFMS
ชื่อบริษัทFresenius Medical Care AG
วันที่เสนอขายครั้งแรกOct 02, 1996
ก่อตั้งเมื่อ2006
ซีอีโอDr. Katarzyna Mazur-Hofsaess
จำนวนพนักงาน- -
ประเภทการรักษาความปลอดภัยOrdinary Share
สิ้นปีงบประมาณOct 02
ที่อยู่Else-Kroener-Strasse 1
เมืองBAD HOMBURG VOR DER HOHE
ตลาดหลักทรัพย์TSX Venture Exchange (former Canadian Ventures Exchange)
ประเทศGermany
รหัสไปรษณีย์61352
โทรศัพท์4961726090
เว็บไซต์https://www.freseniusmedicalcare.com/
รหัสบริษัทFMS
วันที่เสนอขายครั้งแรกOct 02, 1996
ก่อตั้งเมื่อ2006
มีการจ่ายเงินปันผลเป็นจำนวนรวม
1.94B
USD ในช่วง 5 ปีที่ผ่านมา
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020